Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Operating Income: 2012-2024

Historic Operating Income for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to -$171.8 million.

  • Ocular Therapeutix's Operating Income fell 49.35% to -$68.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$250.8 million, marking a year-over-year decrease of 77.57%. This contributed to the annual value of -$171.8 million for FY2024, which is 108.52% down from last year.
  • Per Ocular Therapeutix's latest filing, its Operating Income stood at -$171.8 million for FY2024, which was down 108.52% from -$82.4 million recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's Operating Income registered a high of -$62.8 million during FY2020, and its lowest value of -$171.8 million during FY2024.
  • Moreover, its 3-year median value for Operating Income was -$82.4 million (2023), whereas its average is -$110.9 million.
  • As far as peak fluctuations go, Ocular Therapeutix's Operating Income climbed by 26.75% in 2020, and later crashed by 108.52% in 2024.
  • Ocular Therapeutix's Operating Income (Yearly) stood at -$62.8 million in 2020, then decreased by 24.17% to -$78.0 million in 2021, then dropped by 0.79% to -$78.7 million in 2022, then dropped by 4.74% to -$82.4 million in 2023, then plummeted by 108.52% to -$171.8 million in 2024.